Jaguar Health (JAGX) Share-based Compensation (2014 - 2026)
Jaguar Health (JAGX) reported Share-based Compensation of $155000.0 for Q1 2026, down 48.5% year-over-year from $301000.0 in Q1 2025, and up 33.62% quarter-over-quarter from $116000.0 in Q4 2025.
Jaguar Health (JAGX) Share-based Compensation (2014 - 2026) Analysis & Trends
Jaguar Health (JAGX) has 13 years of Share-based Compensation data on file, last reported at $155000.0 in Q1 2026.
- Share-based Compensation for Q1 2026 came in at $155000.0, down 48.5% year-over-year; the trailing twelve-month figure through Mar 2026 was $685000.0 (down 49.85% YoY), and the FY2025 annual result was $831000.0, down 49.36% from the prior year.
- Share-based Compensation improved to $155000.0 in Q1 2026 per JAGX's latest filing, from $116000.0 in the prior quarter.
- Over five years, Share-based Compensation peaked at $1.1 million in Q1 2022 and troughed at $116000.0 in Q4 2025.
- A 5-year average of $463882.4 and a median of $397000.0 in 2022 frame the typical range for Share-based Compensation.
- The sharpest annual moves came in 2022 and 2025: Share-based Compensation jumped 67.67% in 2022, then sank 68.82% in 2025.
- A 5-year view of Share-based Compensation shows it stood at $397000.0 in 2022, then soared by 45.34% to $577000.0 in 2023, then slumped by 35.53% to $372000.0 in 2024, then slumped by 68.82% to $116000.0 in 2025, then soared by 33.62% to $155000.0 in 2026.
- Business Quant data shows JAGX's Share-based Compensation at $155000.0 in Q1 2026, $116000.0 in Q4 2025, and $135000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | - |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | 305,000.00 |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | 166.40 Mn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | 26.47 Mn |
| 10 | Jaguar Health | 1.44 Mn | -10.19 Mn | 19.11 Mn | 155,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 155,000.00 |
| Mar 31, 2026 | 155,000.00 |
| Dec 31, 2025 | 116,000.00 |
| Dec 31, 2025 | 116,000.00 |
| Sep 30, 2025 | 135,000.00 |
| Sep 30, 2025 | 135,000.00 |
| Jun 30, 2025 | 279,000.00 |
| Jun 30, 2025 | 279,000.00 |
| Mar 31, 2025 | 301,000.00 |
| Mar 31, 2025 | 301,000.00 |
| Dec 31, 2024 | 372,000.00 |
| Dec 31, 2024 | 372,000.00 |
| Sep 30, 2024 | 310,000.00 |
| Sep 30, 2024 | 310,000.00 |
| Jun 30, 2024 | 383,000.00 |
| Jun 30, 2024 | 383,000.00 |
| Mar 31, 2024 | 581,000.00 |
| Mar 31, 2024 | 581,000.00 |
| Dec 31, 2023 | 577,000.00 |
| Dec 31, 2023 | 577,000.00 |